A Novel Anti-Inflammatory and Anti-Fibrotic Agent, EBP979, Treatment Ameliorates Angiotensin II-Induced Ventricular Remodelling and Vascular Dysfunction

This study aimed to investigate the therapeutic potential of a novel anti-inflammatory and anti-fibrotic compound, EBP979, in young and old, female and male mice with angiotensin II (AngII) infusion.

Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: B. Wang, H. Liu, R. Magaye, S. Bailey, H. Kiriazis, D. Donner, B. Kemp-Harper, D. Kaye Source Type: research